Year: 2016
Type: dissertation
Abstract: Schizophrenia, a psychotic disorder that affects between 0,4 and 0,8 % of the population, is believed to result from an imbalance between glutamatergic and dopaminergic neurotransmission systems during neurodevelopment. In particular, alterations in glutamate N-methyl-D-aspartate (NMDA) and dopamine receptor signaling and trafficking are associated with the disease. As an example, NMDA receptor (NMDAR) antagonists can mimic in healthy individuals some of the symptoms associated with the disease, and alterations in NMDA receptor expression have been reported both in brain samples from patients and in experimental models of schizophrenia. However, the mechanisms underlying these impairments remain elusive. Long considered as immobile at the cell surface, neurotransmitter receptors are instead highly dynamic and diffuse laterally within the membrane plane. Surface diffusion recently emerged as a key regulator controlling the synaptic content in NMDAR to shape the strength of excitatory neurotransmissions. It also contributes to the dialogue between glutamatergic and dopaminergic pathways through dopamine D1 receptor (D1R)/NMDAR interaction-based surface redistributions of receptors. Moreover, changes in NMDAR surface diffusion have been reported in autoimmune neuropsychiatric disorders, suggesting that impaired receptor surface dynamics could contribute to psychosis. To address this challenging question, we assessed whether a psychotomimetic molecule, ketamine, acutely impacts NMDAR surface dynamics and distribution. We then explored if neuroleptics used to alleviate the symptoms of schizophrenia rescue ketamine-induced deficits in NMDAR surface trafficking. Our results show that NMDAR surface diffusion is decreased following acute application of ketamine, an effect which preferentially impacts extrasynaptic GluN2A subunit-containing NMDAR. Importantly, the atypical antipsychotic clozapine had the opposite action and increased the surface diffusion of GluN2A-NMDAR in perisynaptic and synaptic compartments, and of GluN2B-NMDAR at extrasynaptic sites, although it did not significantly affect the surface expression or synaptic localization of NMDAR as attested by immunostaining experiments. On the contrary, haloperidol, a typical first-generation neuroleptic, did not impact NMDAR surface dynamics. When combined with ketamine, clozapine successfully prevented the impairments in GluN2A-NMDAR surface diffusion elicited by the psychotomimetic molecule. Altogether, these results suggest that impairments in NMDAR surface trafficking could represent a new hallmark of psychotic disorders, and that one of the actions of atypical neuroleptics could be to restore NMDAR dynamics at the cell surface.
Author: Fernandes, Alexandra
Institution: University of Coimbra
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7224044595
